Quest Diagnostics Nichols Institute
Quest Diagnostics Nichols Institute was paid $39.93M by Medicaid between Jan 2018 and Dec 2024, across 406 billing codes. Its largest line is 81420, Fetal chromosomal aneuploidy genomic sequence analysis panel — 24% of everything it billed.
SAN JUAN CAPISTRANO, CA 92675
Next to other Clinical Medical Laboratory providers in California
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 140,145 | $2.03M | |
| 2019 | 116,056 | $1.95M | |
| 2020 | 123,138 | $2.91M | |
| 2021 | 134,143 | $3.70M | |
| 2022 | 236,970 | $10.34M | |
| 2023 | 224,013 | $8.95M | |
| 2024incomplete | 218,485 | $10.05M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 24% | 34,229 | 31,676 | $9.44M |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 16% | 39,795 | 38,124 | $6.45M |
| 81443 | 5.5% | 3,358 | 3,265 | $2.19M | |
| 81329 | 4.5% | 25,921 | 25,015 | $1.82M | |
| 87799 | 2.4% | 17,067 | 12,304 | $975K | |
| 87801 | Infectious agent detection by nucleic acid; amplified probe, multiple organisms | 2.4% | 18,510 | 17,197 | $971K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 2.1% | 24,013 | 21,937 | $835K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 2.1% | 23,920 | 21,875 | $829K |
| 87902 | 2.0% | 4,251 | 3,948 | $780K | |
| 83520 | 1.3% | 48,152 | 34,324 | $501K | |
| 87901 | 1.2% | 3,305 | 3,074 | $495K | |
| 86235 | 1.2% | 9,395 | 7,610 | $471K |
394 more codes
| 87536 | 1.2% | 7,878 | $462K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 14,728 | $382K |
| 87512 | <1% | 10,674 | $363K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 4,832 | $327K |
| 83993 | <1% | 24,124 | $313K | |
| 88185 | <1% | 3,491 | $289K | |
| 86635 | <1% | 9,749 | $287K | |
| 87900 | <1% | 3,319 | $277K | |
| 82670 | <1% | 14,463 | $271K | |
| 81596 | <1% | 16,205 | $270K | |
| 82672 | <1% | 16,984 | $269K | |
| 87522 | Neg quan hep c or qual rna | <1% | 7,653 | $248K |
| 84305 | <1% | 16,221 | $229K | |
| 86147 | <1% | 11,135 | $228K | |
| 82677 | <1% | 13,573 | $213K | |
| 86146 | <1% | 7,728 | $206K | |
| 82105 | <1% | 15,149 | $200K | |
| 86336 | <1% | 13,711 | $196K | |
| 84702 | <1% | 19,798 | $185K | |
| 84445 | <1% | 4,851 | $180K | |
| 87906 | <1% | 1,976 | $166K | |
| 82542 | <1% | 12,793 | $163K | |
| 83516 | <1% | 20,998 | $160K | |
| 84403 | <1% | 6,680 | $157K | |
| 81243 | <1% | 15,215 | $155K | |
| 82172 | <1% | 14,034 | $155K | |
| 86696 | <1% | 9,667 | $154K | |
| 83704 | <1% | 7,237 | $145K | |
| 83498 | <1% | 7,756 | $141K | |
| 86003 | <1% | 8,747 | $132K | |
| 83698 | <1% | 6,220 | $129K | |
| 86255 | <1% | 25,809 | $124K | |
| 81513 | <1% | 2,460 | $124K | |
| 84681 | <1% | 10,392 | $123K | |
| 81229 | <1% | 411 | $123K | |
| 86341 | <1% | 11,374 | $120K | |
| 87529 | <1% | 4,082 | $119K | |
| 82671 | <1% | 4,447 | $119K | |
| 82530 | <1% | 8,885 | $116K | |
| 82626 | <1% | 6,824 | $114K | |
| 81512 | <1% | 3,505 | $113K | |
| 88262 | <1% | 1,192 | $112K | |
| 82157 | <1% | 5,797 | $109K | |
| 81206 | <1% | 815 | $106K | |
| 86360 | <1% | 2,889 | $101K | |
| 82088 | <1% | 3,325 | $98K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 1,862 | $96K |
| 86787 | <1% | 8,699 | $94K | |
| 86160 | <1% | 6,610 | $93K | |
| 83001 | <1% | 8,176 | $93K | |
| 83002 | <1% | 8,697 | $92K | |
| 82107 | <1% | 2,306 | $91K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 2,894 | $87K |
| 83519 | <1% | 10,248 | $85K | |
| 84402 | <1% | 4,461 | $84K | |
| 86682 | <1% | 10,008 | $82K | |
| 82652 | <1% | 2,444 | $80K | |
| 86695 | <1% | 8,560 | $80K | |
| 84482 | <1% | 7,201 | $75K | |
| 83525 | <1% | 9,936 | $74K | |
| 82397 | <1% | 7,616 | $74K | |
| 88230 | <1% | 1,148 | $74K | |
| 82024 | <1% | 2,931 | $74K | |
| 86337 | <1% | 5,256 | $72K | |
| 82784 | <1% | 10,872 | $72K | |
| 86038 | <1% | 9,681 | $71K | |
| 88184 | <1% | 3,271 | $70K | |
| 83695 | <1% | 8,073 | $68K | |
| 86141 | <1% | 6,835 | $68K | |
| 87563 | <1% | 3,522 | $68K | |
| 81240 | <1% | 2,999 | $66K | |
| 83883 | <1% | 7,735 | $64K | |
| 80061 | Lipid panel | <1% | 10,140 | $63K |
| 84244 | <1% | 3,513 | $63K | |
| 86361 | <1% | 2,957 | $59K | |
| 86376 | <1% | 6,449 | $57K | |
| 83921 | <1% | 5,096 | $57K | |
| 83013 | <1% | 947 | $56K | |
| 87497 | <1% | 1,573 | $55K | |
| 84140 | <1% | 4,365 | $53K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 36,002 | $53K |
| 86200 | <1% | 7,383 | $52K | |
| 87517 | <1% | 1,635 | $52K | |
| 81270 | <1% | 836 | $51K | |
| 88189 | <1% | 2,938 | $50K | |
| 83880 | <1% | 2,247 | $50K | |
| 85245 | <1% | 3,395 | $49K | |
| 85246 | <1% | 3,505 | $48K | |
| 81241 | <1% | 4,756 | $47K | |
| 82679 | <1% | 2,782 | $46K | |
| 87535 | <1% | 1,435 | $43K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,078 | $42K |
| 86364 | <1% | 5,327 | $40K | |
| 85240 | <1% | 3,658 | $40K | |
| 84144 | <1% | 3,417 | $40K | |
| 87662 | <1% | 1,255 | $40K | |
| 86753 | <1% | 5,987 | $39K | |
| 86780 | <1% | 3,306 | $38K | |
| 84182 | <1% | 680 | $38K | |
| 82681 | <1% | 2,070 | $36K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 1,890 | $36K |
| 82166 | <1% | 2,117 | $36K | |
| 83655 | <1% | 3,869 | $36K | |
| 85306 | <1% | 2,501 | $35K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 786 | $35K |
| 81279 | <1% | 244 | $34K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,001 | $34K |
| 82104 | <1% | 3,412 | $32K | |
| 81257 | <1% | 3,068 | $32K | |
| 83010 | <1% | 3,776 | $31K | |
| 85247 | <1% | 1,954 | $31K | |
| 82533 | <1% | 2,959 | $30K | |
| 82384 | <1% | 1,770 | $29K | |
| 86359 | <1% | 1,340 | $29K | |
| 81401 | <1% | 1,587 | $27K | |
| 86316 | <1% | 1,904 | $27K | |
| 82642 | <1% | 1,999 | $26K | |
| 86431 | <1% | 7,374 | $26K | |
| 87631 | <1% | 372 | $26K | |
| 86317 | <1% | 2,819 | $26K | |
| 83090 | <1% | 3,076 | $25K | |
| 85303 | <1% | 2,057 | $24K | |
| 86039 | <1% | 3,484 | $24K | |
| 80354 | <1% | 989 | $24K | |
| 86812 | <1% | 1,130 | $24K | |
| 80348 | <1% | 117 | $24K | |
| 81162 | <1% | 72 | $23K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 809 | $22K |
| 82653 | <1% | 3,762 | $21K | |
| 86381 | <1% | 1,549 | $21K | |
| 83527 | <1% | 2,168 | $20K | |
| 86628 | <1% | 1,637 | $20K | |
| 80050 | General health panel | <1% | 885 | $20K |
| 82139 | <1% | 1,974 | $20K | |
| 82379 | <1% | 1,931 | $19K | |
| 86148 | <1% | 1,906 | $19K | |
| 86803 | <1% | 1,659 | $18K | |
| 85730 | <1% | 4,538 | $18K | |
| 84146 | <1% | 943 | $18K | |
| 81256 | <1% | 1,821 | $17K | |
| 80299 | <1% | 1,537 | $17K | |
| 86794 | <1% | 1,653 | $17K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,682 | $17K |
| 84432 | <1% | 1,209 | $16K | |
| 84165 | <1% | 2,458 | $16K | |
| 83835 | <1% | 1,348 | $16K | |
| 85300 | <1% | 1,794 | $16K | |
| 86021 | <1% | 1,676 | $15K | |
| 81219 | <1% | 164 | $15K | |
| 86382 | <1% | 939 | $15K | |
| 84425 | <1% | 776 | $15K | |
| 81511 | <1% | 1,266 | $15K | |
| 80053 | Comprehensive metabolic panel | <1% | 2,230 | $14K |
| 85613 | <1% | 2,166 | $14K | |
| 86258 | <1% | 1,008 | $14K | |
| 84439 | <1% | 3,068 | $14K | |
| 87209 | <1% | 1,075 | $14K | |
| 81207 | <1% | 128 | $14K | |
| 83021 | <1% | 1,040 | $13K | |
| 87634 | <1% | 417 | $13K | |
| 84143 | <1% | 909 | $13K | |
| 84153 | <1% | 1,438 | $12K | |
| 80349 | <1% | 615 | $12K | |
| 83631 | <1% | 1,087 | $12K | |
| 82657 | <1% | 939 | $12K | |
| 87481 | <1% | 432 | $12K | |
| 82787 | <1% | 801 | $12K | |
| 81339 | <1% | 148 | $11K | |
| 82103 | <1% | 1,393 | $11K | |
| 84080 | <1% | 996 | $11K | |
| 84260 | <1% | 645 | $11K | |
| 84270 | <1% | 519 | $11K | |
| 86618 | <1% | 695 | $11K | |
| 82977 | <1% | 3,832 | $10K | |
| 86665 | <1% | 739 | $10K | |
| 82985 | <1% | 1,191 | $10K | |
| 82570 | <1% | 3,614 | $10K | |
| 86162 | <1% | 857 | $10K | |
| 86015 | <1% | 1,528 | $9K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,792 | $9K |
| 86671 | <1% | 813 | $9K | |
| 83970 | <1% | 316 | $9K | |
| 87340 | <1% | 1,012 | $9K | |
| 82785 | <1% | 799 | $8K | |
| 86762 | <1% | 684 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 280 | $8K |
| 87625 | <1% | 260 | $8K | |
| 80074 | <1% | 186 | $8K | |
| 82247 | <1% | 2,740 | $8K | |
| 81364 | <1% | 119 | $7K | |
| 81291 | <1% | 2,358 | $7K | |
| 86225 | <1% | 714 | $7K | |
| 87177 | <1% | 1,086 | $7K | |
| 84460 | <1% | 2,737 | $7K | |
| 86790 | <1% | 1,035 | $7K | |
| 83918 | <1% | 566 | $7K | |
| 86343 | <1% | 763 | $7K | |
| 86769 | <1% | 170 | $6K | |
| 82656 | <1% | 757 | $6K | |
| 87467 | <1% | 1,208 | $6K | |
| 80145 | <1% | 326 | $6K | |
| 86596 | <1% | 429 | $6K | |
| 86800 | <1% | 636 | $6K | |
| 86666 | <1% | 795 | $6K | |
| 86334 | <1% | 446 | $6K | |
| 81332 | <1% | 521 | $6K | |
| 84145 | <1% | 327 | $6K | |
| 85301 | <1% | 627 | $5K | |
| 87109 | <1% | 558 | $5K | |
| 88142 | <1% | 306 | $5K | |
| 86592 | <1% | 1,665 | $5K | |
| 84484 | <1% | 713 | $5K | |
| 84238 | <1% | 165 | $5K | |
| 86692 | <1% | 442 | $5K | |
| 86757 | <1% | 464 | $5K | |
| 82728 | <1% | 767 | $5K | |
| 86036 | <1% | 680 | $5K | |
| 86480 | <1% | 95 | $4K | |
| 86774 | <1% | 400 | $4K | |
| 83497 | <1% | 554 | $4K | |
| 84206 | <1% | 284 | $4K | |
| 83020 | <1% | 477 | $4K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 173 | $4K |
| 82010 | <1% | 802 | $4K | |
| 84436 | <1% | 1,662 | $4K | |
| 82017 | <1% | 383 | $4K | |
| 82610 | <1% | 311 | $3K | |
| 85027 | <1% | 689 | $3K | |
| 83006 | <1% | 272 | $3K | |
| 86738 | <1% | 166 | $3K | |
| 85385 | <1% | 687 | $3K | |
| 86008 | <1% | 241 | $3K | |
| 86140 | <1% | 766 | $3K | |
| 86664 | <1% | 446 | $3K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 42 | $3K |
| 86231 | <1% | 530 | $3K | |
| 84075 | <1% | 743 | $3K | |
| 82705 | <1% | 801 | $3K | |
| 86052 | <1% | 358 | $3K | |
| 86041 | <1% | 359 | $3K | |
| 84155 | <1% | 1,237 | $3K | |
| 86708 | <1% | 401 | $2K | |
| 80230 | <1% | 128 | $2K | |
| 83550 | <1% | 552 | $2K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 594 | $2K |
| 84478 | <1% | 2,397 | $2K | |
| 87046 | <1% | 368 | $2K | |
| 82550 | <1% | 440 | $2K | |
| 82465 | <1% | 2,409 | $2K | |
| 84120 | <1% | 243 | $2K | |
| 80177 | <1% | 285 | $2K | |
| 86340 | <1% | 195 | $2K | |
| 87230 | <1% | 173 | $2K | |
| ATP03 | <1% | 300 | $2K | |
| 83718 | <1% | 2,547 | $2K | |
| 87912 | <1% | 12 | $2K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 275 | $2K |
| 80361 | <1% | 1,128 | $2K | |
| 80081 | <1% | 39 | $2K | |
| 83540 | <1% | 567 | $2K | |
| 86648 | <1% | 164 | $2K | |
| 87081 | <1% | 305 | $2K | |
| 86735 | <1% | 100 | $2K | |
| 82595 | <1% | 370 | $2K | |
| 85652 | <1% | 850 | $2K | |
| 82607 | <1% | 483 | $2K | |
| 86704 | <1% | 343 | $2K | |
| 83014 | <1% | 244 | $2K | |
| 84630 | <1% | 205 | $2K | |
| 82552 | <1% | 161 | $2K | |
| 86606 | <1% | 122 | $2K | |
| 86042 | <1% | 188 | $2K | |
| 84481 | <1% | 259 | $2K | |
| 82955 | <1% | 265 | $1K | |
| 85041 | <1% | 611 | $1K | |
| 86615 | <1% | 105 | $1K | |
| 87338 | <1% | 176 | $1K | |
| 86355 | <1% | 53 | $1K | |
| 83625 | <1% | 131 | $1K | |
| 86043 | <1% | 221 | $1K | |
| 82365 | <1% | 144 | $1K | |
| 87449 | <1% | 171 | $1K | |
| 84588 | <1% | 60 | $1K | |
| 86215 | <1% | 147 | $1K | |
| 84163 | <1% | 131 | $1K | |
| 85014 | <1% | 637 | $1K | |
| 86765 | <1% | 70 | $1K | |
| 83615 | <1% | 258 | $1K | |
| 85018 | <1% | 612 | $1K | |
| 86362 | <1% | 116 | $1K | |
| 80365 | <1% | 1,080 | $1K | |
| 86706 | <1% | 256 | $1K | |
| 86850 | <1% | 125 | $1K | |
| 85598 | <1% | 63 | $957.88 | |
| 82164 | <1% | 212 | $952.30 | |
| 84433 | <1% | 550 | $873.02 | |
| 80321 | <1% | 273 | $850.17 | |
| 82941 | <1% | 67 | $846.01 | |
| 87581 | <1% | 39 | $836.95 | |
| 87088 | <1% | 114 | $826.79 | |
| 85597 | <1% | 89 | $795.66 | |
| 82310 | <1% | 193 | $779.31 | |
| 81479 | Unlisted molecular pathology procedure | <1% | 1,397 | $759.61 |
| 82746 | <1% | 187 | $739.51 | |
| 88360 | <1% | 12 | $737.62 | |
| 85305 | <1% | 78 | $720.38 | |
| 86644 | <1% | 84 | $708.09 | |
| 86023 | <1% | 82 | $701.30 | |
| 83521 | <1% | 18 | $682.18 | |
| 81335 | <1% | 73 | $660.44 | |
| 86684 | <1% | 57 | $659.85 | |
| 82507 | <1% | 29 | $653.92 | |
| 86617 | <1% | 27 | $595.81 | |
| 86593 | <1% | 188 | $592.32 | |
| 87538 | <1% | 26 | $554.22 | |
| 84585 | <1% | 64 | $553.91 | |
| 86609 | <1% | 126 | $537.74 | |
| 81283 | <1% | 39 | $534.33 | |
| 83735 | <1% | 128 | $498.47 | |
| 86901 | <1% | 138 | $489.45 | |
| 81400 | <1% | 57 | $473.82 | |
| 86900 | <1% | 138 | $465.51 | |
| 86663 | <1% | 69 | $433.08 | |
| 99001 | <1% | 183 | $422.45 | |
| 82390 | <1% | 72 | $404.88 | |
| 84207 | <1% | 26 | $402.92 | |
| 86747 | <1% | 14 | $387.74 | |
| 85302 | <1% | 41 | $384.11 | |
| 83945 | <1% | 35 | $382.14 | |
| 86638 | <1% | 26 | $370.79 | |
| 81403 | <1% | 43 | $370.40 | |
| 81226 | <1% | 54 | $363.06 | |
| 86001 | <1% | 24 | $361.48 | |
| 86611 | <1% | 44 | $357.81 | |
| 87186 | <1% | 70 | $352.32 | |
| 84311 | <1% | 72 | $344.01 | |
| 85610 | <1% | 153 | $342.05 | |
| 82085 | <1% | 46 | $339.59 | |
| 86256 | <1% | 45 | $335.27 | |
| 81306 | <1% | 28 | $322.66 | |
| 84550 | <1% | 66 | $308.32 | |
| 83630 | <1% | 40 | $289.43 | |
| 85307 | <1% | 26 | $274.17 | |
| 82634 | <1% | 16 | $268.76 | |
| 86622 | <1% | 40 | $262.47 | |
| 81508 | <1% | 17 | $248.64 | |
| 84466 | <1% | 25 | $247.75 | |
| 81225 | <1% | 54 | $237.68 | |
| 82525 | <1% | 27 | $236.94 | |
| 81227 | <1% | 52 | $226.53 | |
| 83690 | <1% | 88 | $204.43 | |
| 87484 | <1% | 16 | $203.51 | |
| 87468 | <1% | 16 | $203.51 | |
| 86161 | <1% | 26 | $202.26 | |
| 81231 | <1% | 53 | $191.43 | |
| 81230 | <1% | 53 | $191.43 | |
| 81232 | <1% | 40 | $191.43 | |
| 81001 | <1% | 191 | $176.62 | |
| 80175 | <1% | 15 | $160.01 | |
| 87254 | <1% | 17 | $150.14 | |
| 82340 | <1% | 28 | $141.59 | |
| 82668 | <1% | 28 | $141.05 | |
| 82523 | <1% | 16 | $139.13 | |
| 84590 | <1% | 26 | $135.94 | |
| 84105 | <1% | 28 | $124.95 | |
| 84392 | <1% | 27 | $119.78 | |
| 87168 | <1% | 30 | $118.23 | |
| 84300 | <1% | 27 | $114.06 | |
| 84560 | <1% | 28 | $108.91 | |
| 84133 | <1% | 27 | $105.07 | |
| 87300 | <1% | 17 | $101.53 | |
| 81328 | <1% | 27 | $95.40 | |
| 81350 | <1% | 43 | $85.25 | |
| 84154 | <1% | 13 | $84.99 | |
| 80346 | <1% | 27 | $83.84 | |
| 82043 | <1% | 37 | $80.04 | |
| 83986 | <1% | 27 | $78.24 | |
| 81247 | <1% | 28 | $75.96 | |
| 82950 | <1% | 12 | $66.12 | |
| 82150 | <1% | 15 | $60.30 | |
| 82040 | <1% | 16 | $56.55 | |
| 87427 | <1% | 14 | $55.86 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 12 | $54.28 |
| 83721 | <1% | 60 | $52.72 | |
| 82565 | <1% | 13 | $51.21 | |
| 83529 | <1% | 12 | $44.34 | |
| 81355 | <1% | 27 | $38.34 | |
| 87045 | <1% | 13 | $33.05 | |
| 84480 | <1% | 13 | $26.39 | |
| 0346U | <1% | 13 | $18.65 | |
| 80324 | 0% | 13 | $0.00 | |
| 0001M | 0% | 14 | $0.00 | |
| 81381 | 0% | 27 | $0.00 | |
| 80362 | 0% | 19 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.